These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24450842)

  • 1. Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia.
    Henn A; Mellon G; Benoît H; Roos-Weil D; Jauréguiberry S; Mordant P; Fekkar A; Caumes E
    Scand J Infect Dis; 2014 Mar; 46(3):231-4. PubMed ID: 24450842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
    Roux C; Thyss A; Gari-Toussaint M
    J Mycol Med; 2013 Dec; 23(4):270-3. PubMed ID: 24210582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
    Dilhuydy MS; Jouary T; Demeaux H; Ravaud A
    Br J Haematol; 2007 Jun; 137(6):490. PubMed ID: 17425643
    [No Abstract]   [Full Text] [Related]  

  • 4. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
    Pitini V; Cascio A; Arrigo C; Altavilla G
    Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
    Bassetti M; Repetto E; Mikulska M; Miglino M; Clavio M; Gobbi M; Righi E; Viscoli C
    J Chemother; 2009 Apr; 21(2):211-4. PubMed ID: 19423476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia.
    Karia S; Jeyapalan K; Kennedy B
    Br J Haematol; 2011 Apr; 153(2):147. PubMed ID: 21332707
    [No Abstract]   [Full Text] [Related]  

  • 7. Alemtuzumab and myelodysplasia: a story of love and hate (possible alemtuzumab-induced myelodysplastic changes).
    Braester A; Akria L; Suriu C; Sonkin V
    Acta Haematol; 2013; 129(3):185-6. PubMed ID: 23257842
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
    Saadeh CE; Srkalovic G
    Pharmacotherapy; 2008 Feb; 28(2):281-4. PubMed ID: 18225973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pact with the devil: alemtuzumab therapy, immune suppression and infectious complications in chronic lymphocytic leukemia.
    Antohe I; Dascalescu A; Burcoveanu C; Ghiorghiu D; Dascalu A; Danaila C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):92-5. PubMed ID: 24741782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Reda G; Maura F; Gritti G; Gregorini A; Binda F; Guidotti F; Piciocchi A; Visco C; Rodeghiero F; Cortelezzi A
    Am J Hematol; 2012 Sep; 87(9):936-7. PubMed ID: 22718434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients.
    Cortelezzi A; Gritti G; Laurenti L; Cuneo A; Ciolli S; Di Renzo N; Musto P; Mauro FR; Cascavilla N; Falchi L; Zallio F; Callea V; Maura F; Martinelli S; Piciocchi A; Reda G; Foà R;
    Br J Haematol; 2012 Feb; 156(4):481-9. PubMed ID: 22150204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndrome.
    Gibbs SD; Herbert KE; McCormack C; Seymour JF; Prince HM
    Eur J Haematol; 2004 Dec; 73(6):447-9. PubMed ID: 15522069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia.
    Anoop P; Stanford M; Saso R; Dearden CE
    J Infect Chemother; 2010 Apr; 16(2):150-1. PubMed ID: 20108019
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia.
    Anoop P; Wotherspoon A; Matutes E
    Br J Haematol; 2010 Feb; 148(3):484-6. PubMed ID: 19874308
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia.
    Tse E; Leung RY; Kwong YL
    Ann Hematol; 2015 Jan; 94(1):165-7. PubMed ID: 24879095
    [No Abstract]   [Full Text] [Related]  

  • 16. A fatal case of alemtuzumab-associated interstitial pneumonitis.
    Creelan B; Ferber A
    Am J Ther; 2008; 15(1):82-4. PubMed ID: 18223357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
    Isidoro L; Pires P; Rito L; Cordeiro G
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24403383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obinutuzumab (Gazyva) for chronic lymphocytic leukemia.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):e114-5. PubMed ID: 25538980
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
    Grey M
    Br J Haematol; 2008 Jul; 142(1):1. PubMed ID: 18477054
    [No Abstract]   [Full Text] [Related]  

  • 20. Alemtuzumab for B-cell chronic lymphocytic leukemia.
    Robak T
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1033-51. PubMed ID: 18588450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.